Academic Radiology
Volume 16, Issue 2 , Pages 194-199 , February 2009

Progression of Coronary Atherosclerosis After Heart Transplantation on Electron-beam Computed Tomography

  • Friedrich D. Knollmann, MD, PhD

      Affiliations

    • Department of Radiology, University of Pittsburgh Medical Center, 200 Lothrop Street, Suite E-177 PUH, Pittsburgh, PA 15213-2582
    • Corresponding Author InformationAddress correspondence to: F.D.K.
    • ,
  • Franziska Stühmer

      Affiliations

    • Department of Radiology, Charité, Virchow Hospital Campus, Humboldt University of Berlin, Berlin, Germany
    • ,
  • Hans Lehmkuhl, MD

      Affiliations

    • Department of Cardiothoracic and Vascular Surgery, German Heart Institute, Berlin, Germany
    • ,
  • Roland Felix, MD, PhD

      Affiliations

    • Department of Radiology, Charité, Virchow Hospital Campus, Humboldt University of Berlin, Berlin, Germany
    • ,
  • Roland Hetzer, MD, PhD

      Affiliations

    • Department of Cardiothoracic and Vascular Surgery, German Heart Institute, Berlin, Germany

Received 6 June 2008 ,Accepted 8 July 2008.

References 

  1. Hosenpud JD, Bennet LE, Keck BM, Fiol B, Boucek MM, Novick RJ. The registry of the International Society for Heart and Lung Transplantation: sixteenth official report—1999. J Heart Lung Transplant. 1999;18:611–626
  2. St. Goar FG, Pinto FJ, Alderman EL, et al. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of “angiographically silent” intimal thickening. Circulation. 1992;85:979–987
  3. Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med. 2003;349:847–858
  4. Ramzy D, Rao V, Brahm J, Mirikuga S, Delgado D, Ross HJ. Cardiac allograft vasculopathy: a review. Can J Surg. 2005;48:319–327
  5. Budoff MJ, Georgiou D, Brody A, et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease. Circulation. 1996;93:898–904
  6. Knollmann FD, Bocksch W, Spieglsberger S, Hetzer R, Felix R, Hummel M. Electron-beam computed tomography in the assessment of coronary artery disease after heart transplantation. Circulation. 2000;101:2078–2082
  7. Farzaneh-Far A. Electron-beam computed tomography in the assessment of coronary artery disease after heart transplantation (letter to the editor). Circulation. 2001;103:e60
  8. Knollmann FD, Felix R, Bocksch W, Spiegelsberger S, Hummel M, Hetzer R. Electron-beam computed tomography in the assessment of coronary artery disease after heart transplantation (letter to the editor). Circulation. 2001;103:e60
  9. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo D. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med. 1998;339:1972–1978
  10. Koashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 1995;333:621–627
  11. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano F. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–832
  12. Budoff MJ, Lane KL, Bakhsheshi H, et al. Rates of progression of coronary calcium by electron beam tomography. Am J Cardiol. 2000;86:8–11
  13. Achenbach S, Ropers D, Pohle K, et al. Influence of lipid-lowering therapy on the progression of coronary artery calcification. Circulation. 2002;106:1077–1082
  14. Grauhan O, Patzurek J, Hummel M, et al. Donor-transmitted coronary atherosclerosis. J Heart Lung Transplant. 2003;22:568–573
  15. Rumberger JA, Kaufman L. A Rosetta stone for coronary calcium risk stratification: Agatston, volume and mass scores in 11490 individuals. AJR Am J Roentgenol. 2003;181:743–748
  16. Schmermund A, Erbel R, Silber S. Age and gender distribution of coronary artery calcium measured by four-slice computed tomography in 2030 persons with no symptoms of coronary artery disease. Am J Cardiol. 2002;90:168–173
  17. Yoon HC, Emerick AM, Hill JA, Gjertson DW, Goldin JG. Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects. Radiology. 2002;224:236–241
  18. Rahnami M, Cruz RP, Granville DJ, McManus BM. Allograft vasculopathy versus atherosclerosis. Circ Res. 2006;99:801–815
  19. Li H, Tanaka K, Anzai H, et al. Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes of heart transplant recipients. J Am Coll Cardiol. 2006;47:2470–2476
  20. Schmermund A, Achenbach S, Budde T, et al. Effect of intensive standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months. Circulation. 2006;113:427–437
  21. Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. J Am Coll Cardiol. 2005;46:166–172
  22. Raggi P, Davidson M, Callister TQ, et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering With EBT Scanning (BELLES). Circulation. 2005;112:563–571
  23. Redberg RF. Coronary artery calcium—should we rely on this surrogate marker?. Circulation. 2006;113:336–337

PII: S1076-6332(08)00417-0

doi: 10.1016/j.acra.2008.07.014

Academic Radiology
Volume 16, Issue 2 , Pages 194-199 , February 2009

Article Tools

* Image Usage & Resolution